← Return to How does one know when it is OK to start a slow taper?
DiscussionHow does one know when it is OK to start a slow taper?
Polymyalgia Rheumatica (PMR) | Last Active: Mar 7, 2023 | Replies (13)Comment receiving replies
Replies to "I started on 5 mg last July. Tried my first ds taper starting mid-November. I slowly..."
When was PMR diagnosed? @johnbishop is correct, 5 mg isn't the standard starting dose that doctors usually use for PMR.
It sounds like you are doing the dead slow nearly stop (DSNS) method of tapering. If you think that works for you ... stay with it IF your doctor agrees you should taper that way.
It sounds like you were on 5 mg last July 2022.
You tried the DSNS tapering method in mid-November 2022 and got down to 4 mg in February 2023. Now it sounds like you are back on 5 mg which was the same dose as you were taking last July 2022 ...
Is that right????
If that is all correct, I would just tell your GP you are still on the same dose (5 mg) so you don't confuse your GP.
Your GP probably has no idea what the DSNS method of tapering is. There is no medical research that has been done on this tapering method. I would guess most doctors have never heard of it.
@christi48, If I'm reading correctly, you started at 5 mg prednisone when you were first diagnosed with PMR. I'm not a doctor but that sounds like a really low starting dose. Most starting doses for PMR are 12.5 to 20 mg and it's normally based on your body weight. Folks that weigh less take less or something like that. Here's some info on the topic but it's a little old from 2011.
-- The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114801/.
Also there are a lot of conditions that mimic PMR.
-- Diseases that mimic polymyalgia rheumatica (PMR):
https://www.medicalnewstoday.com/articles/diseases-that-mimic-polymyalgia-rheumatica.
You might want to talk with your GP since you mentioned you don't have a rheumatologist that you trust.